10x Genomics
97.74USD+4.53%Share
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
What's happening?
TXG is outpacing Healthcare this month: +56.0% against +3.8% for the average Healthcare stock.
Above its 200-day average since 7 Nov 2025 · 24 of 34 Healthcare stocks are trending up.
- 1D
- +4.53%
- 7D
- +10.44%
- 1M
- +56.01%
- 3M
- +144.35%
- 6M
- +346.51%
- YTD
- +499.26%
What is the market expecting?
Analysts' mean target sits 36.4% below the price.
Not ranked on value: this stock carries too few of the multiples to score against its sector.
Is the business delivering?
Revenue -12.7% on a year ago; EPS down 150.0% on a year ago; met or beat the estimate in 4 of the last 4 quarters.
Earnings by quarter
Latest quarter -17.9M · -4.46M on the quarter before · -52.5M on a year earlier
- -35.8MOct24+2.14M
- -49.0MFeb25-13.3M
- -34.4MMay25+14.7M
- 34.5MAug25+68.9M
- -27.5MNov25-62.0M
- -16.3MFeb26+11.2M
- -13.5MMay26+2.78M
- -17.9MAug26-4.46M
Net income from the income statement, in USD, by the month it was reported.
How does it compare?
Value rankingTXG is not ranked on value, so there are no nearest stocks to set it against.
What happens next?
Reports next on 5 Nov, in 31 days.
Fundamentals
On the shortlist
TXG isn't in any strategy's Top Matches or Close Matches today.
In the briefing
Briefing for 5 OctThe briefing has not named TXG.
Shortlist history
TXG has not made the shortlist since the ledger opened.
Keep researching
Where next from TXG
Daily market updates
Get the daily brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday to Saturday email.